Capitalizing on Opportunities in Cord Blood Industry Growth - UK by pengxiuhui


More information from

Capitalizing on Opportunities in Cord Blood Industry Growth - UK
Specific Version, with Detailed Company Profiles

Description:    Over the past 12 months, the global cord blood banking industry has expanded through double
                digit growth, due to new entrants in the cord blood banking industry as well as revenue growth at
                existing operations. Deeper analysis reveals that of existing cord blood banks, most fall into one of
                two “camps,” either experiencing flat-line growth (less than 3% per annum) or substantively
                building revenue (17% or more per annum).

                This finding begs the questions:

                - What factors are causing a substantial number of new cord blood banks to open up business? Is it
                the result of a profit opportunity, an effect of advances in therapeutic applications, a social
                response to more parents being aware of the opportunity to store cord stem cells at birth, or are
                other factors driving the activity?

                - What will be the effect of these new entrants to the cord blood banking industry for existing

                - Perhaps most critically, what are the differences among the cord blood banks that are
                experiencing flat-line growth, versus those that have substantively built revenue over the past 12

                Additionally, quantitative analysis reveals that cord blood industry growth has been particularly
                strong within the United Kingdom relative to other regions over the trailing 12 months. This trend is
                expected to continue for a period of 2-3 years, due to unique regulatory and competitive forces
                operating in the region.

                This top-selling report includes detailed analysis of factors that have produced global double-digit
                industry growth over the past year and provides guidance on how to break through flat-line growth
                to become a fast-growing competitor. In addition, as a UK-specific version of the report, it analyzes
                metrics specific to cord blood industry expansion within the United Kingdom.

                Furthermore, the report includes detailed company profiles for all private cord blood banks
                operating within the United Kingdom, including:

                -   Cells4Life Ltd. UK
                -   Cells Limited (a Cryo-Save brand)
                -   Life Cells (previously CryoGenesis International Ltd.)
                -   Future Health Technologies Ltd.
                -   Smart Cells International
                -   UK Cord Blood Bank Ltd.
                -   BioVault Ltd.
                -   Virgin Health Bank
                -   UK Health Solutions Limited (closed operations in 2010)

                Finally, a survey of 1,200 expectant parents is used to provide a roadmap for how cord blood banks
                can best communicate and market their services to potential clients. The findings presented in this
                report reveal specific reasons that parents elect to store cord blood and what factors influence their
                decision-making in choosing a specific bank.

                Target Audience of Report:

                The report will greatly enhance the ability of both public and private cord blood banks to make
                competitive decisions within the UK cord blood banking environment.

                In addition, cord blood companies in surrounding geographic regions may find the UK model of
            growth presented here to be interesting and pertinent to their own business decisions.

            Cord blood companies operating in other global regions that plan to establish a local UK branch will
            benefit from understanding the regional market dynamics presented within the report.

            Research product companies that produce cord blood stem cell products, such as Bio E, Stem Cell
            Technologies, and AllCells, will also find utility in the findings.

            Biotechnology companies that produce equipment for the cord blood banking industry, such as cryo
            -bags, freezers, and cell culture materials will be interested in the report for purposes of
            understanding industry growth dynamics and analyzing the financial state of companies profiled
            within it.

            Organizations entering into long-term collaborative studies with UK cord blood banks will consider
            the content valuable, as will companies with potential interest in company acquisition in the region.
            (This has been common in other regions, with Perkin Elmer acquiring ViaCord, HealthBank Biotech
            acquiring Pacificord, etc.)

            Private investment firms that invest in high-technology sectors, government entities that oversee
            regulation of the cord blood industry, and public health institutions that collect cord blood units may
            also be interested in the report’s findings.

            I. Rate of Entrants to the Cord Blood Banking Industry
            A. Limiting Factors
            1. Accreditations
            2. Security
            3. Laboratory & Storage Requirements
            B. 12 Month Trends
            1. Trailing Twelve Month (TTM) Growth Rates
            2. Revenue Breakdown by Market Component
            3. Critical Analysis of Trends
            II. Bimodal Distribution of Revenue Growth among Global Cord Blood Banks
            A. Flat-Line Growth Companies (< 3% per Year)
            B. Substantive Revenue Growth Companies (17% or More Per Year)
            III. Effect of New Entrants for Existing Competitors

            I. Summary of Conditions
            II. Background
            A. Fetal Cord Blood Characteristics
            B. Existing Treatments
            C. Future Applications
            III. Cord Blood Banking Industry
            A. History
            B. Private vs. Public Cord Blood Banks
            1. UK Private Banks
            a. Overview
            b. Number of Private Banks
            2. UK Public Banking
            3. International Banks
            a. Overview
            b. Number Private Cord Blood Banks by International Region
            IV. Market Characterization
            A. Detailed Company Profiles for Private UK Cord Blood Banks
            1. Cells4Life Ltd. UK
            2. Cells Limited (a Cryo-Save brand)
            3. Life Cells (previously CryoGenesis International Ltd.)
            4. Future Health Technologies Ltd.
            5. Smart Cells International
            6. UK Cord Blood Bank Ltd.
            7. BioVault Ltd.
8. Virgin Health Bank
9. UK Health Solutions Limited (no longer operating)
B. List of International Cord Blood Banks, by Geographic Region
1. U.S. Cord Blood Banks
2. Canadian Cord Blood Banks
3. Mexican Cord Blood Banks
4. South/Central American Cord Blood Banks
5. European Cord Blood Banks
6. Middle Eastern Cord Blood Banks
7. Indian Cord Blood Banks
8. Asian Cord Blood Banks
9. Australian / New Zealand Cord Blood Banks
10. African Cord Blood Banks
C. List of International Public Cord Blood Banks (Alphabetical by Country)
D. Worldwide List of AABB Accredited Cord Blood Facilities
V. International Analysis – Trends, Policies and Industry Conditions (by Country)
1. Canada
2. Mexico
3. United States
4. Brazil
5. Chile
6. Colombia
1. China
2. Japan
3. Korea
4. Malaysia
5. Taiwan
6. Singapore
7. Thailand
1. European Union
a. Policy Overview
b. NETCORD Foundation
2. France
3. Germany & Austria
4. Italy
5. Netherlands
6. Spain
7. Poland
8. Russian Federation
9. United Kingdom
VI. Cost Analysis: Reasons for Variation in Cord Blood Pricing
A. Companies have Flexibility in the Pricing that they Set
B. Companies have Variables in the Services that they Offer
C. Variable Fee Breakdowns
VII. Comparative Analysis of Quality Variables
A. Technical Variables
1. Vapor-Phase Storage vs. Liquid-Phase Storage
2. Cryo-bags vs. Cryo-vials
3. Pentastarch vs. Hetastarch
4. Computer Controlled vs. Manual Rate Freezing
5. Whole Sample vs. Volume Reduction
6. High-Control vs. Low-Control Aseptic Processing
B. Corporate Variables
1. Corporate Stability
2. Scientific Expertise

I. Survey Overview
A. Survey Population
B. Characterization of Market Survey Respondents
1. Geographic Distribution of Market Survey Respondents
2. Household Income Distribution of Survey Respondents
3. Respondent Breakdown by Race
4. Respondent Breakdown by Gender
5. Respondent Breakdown by Level of Education
6. Respondent Breakdown by Location (City vs. Suburban vs. Rural)
7. Regional Breakdown of U.S. Respondents
8. Demographic Conclusions
II. Rates of Awareness: Unaware / Minimally Informed / Moderately Informed /
A. Overall
B. By Gender
C. By Household Income
D. By Education
E. By Race
F. By Geographic Location (City vs. Suburban vs. Rural)
G. By Number of Existing Children within Family (e.g. Birth Order)
III. Factors Influencing Awareness
A. Personal Exposure: Relative Impact of Family, Co-Workers, Peers
B. Informational Sources: Information Sites, Books Medical Pamphlets,
Government Sources
C. Medical Exposure: General Doctors, Ob / Gyn, Midwifes, Nurse, Other
D. Promotional Sources: Internet Advertisements, Print Advertisements,
Radio, TV, Other
IV. Factors Influencing Parental Decision-Making
A. Factors Influencing the Decision Not to Store Cord Blood
1. Knowledge Level
2. Price Sensitivity
3. Safety Concerns
4. Lack of Access
5. Misconceptions
B. Factors Influencing the Decision for Private vs. Public Storage of Cord Blood
1. Ethical Beliefs
2. Gender
3. Total Household Income
4. Level of Education (Highest Level Achieved by at Least One Parent)
5. Race
6. Geographic Location
7. Access to Reliable Healthcare
8. Number of Existing Children within Family (Birth Order)
9. Source of Knowledge
10. Perceived Support of Medical Staff
11. Family Medical History
C. International Analysis of Cord Blood Banking Perceptions (Region-by-Region)
V. Parental Responsiveness to Health Statistics
A. Overview
B. Health Statistics
C. Health Statistic Conclusions
VI. Parental Expectations
A. Quality of Services
B. Willingness to Educate/Inform
C. Reputability of Organization
VII. Informative Websites: Online Sources Utilized by Expectant Parents
A. Overview of Websites
1. Information Only
2. Commercial Affiliation
B. Dominant Regional Websites (International Analysis)
C. Most Important Criteria Used to Identify Sites to Inform Decision-Making
D. Underlying Reasons for Visiting Online Resources
VIII. Trends
A. Rates of Cord Blood Storage (units per year)
            B. Rates of Parental Awareness
            C. Cord Blood Research Publication Rates
            D. Cord Blood Research Funding Levels
            E. Cord Blood Patent Breakdown
            F. Rates of Cord Blood Research Product Development
            IX. Private Cord Blood Banking: The “Model Customer”
            A. Traits of a “Model Customer”
            1. “Model Customer” for a Private Cord Blood Bank
            2. “Model Customer” for a Public Cord Blood Bank
            B. Ideal Price Range
            C. Approaches for Communicating with Expectant Parents

Ordering:   Order Online -

            Order by Fax - using the form below

            Order by Post - print the order form below and sent to

                         Research and Markets,
                         Guinness Centre,
                         Taylors Lane,
                         Dublin 8,
                                                           Page 1 of 2

Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to 646-607-
1907 (from USA) or +353-1-481-1716 (from Rest of World). If you have any questions please visit

Order Information
Please verify that the product information is correct and select the format(s) you require.

               Product Name:           Capitalizing on Opportunities in Cord Blood Industry Growth - UK Specific
                                       Version, with Detailed Company Profiles
               Web Address:  
               Office Code:            OC8HPPJNUQPRR

Product Formats
Please select the product formats and quantity you require:

               Electronic -
                                         EURO €2,777.00
               Single User:

               Hard Copy - :             EURO €2,868.00 + Euro €50 Shipping/Handling *

               Electronic - 1 -
                                         EURO €3,473.00
               10 Users:
               Electronic -
                                         EURO €4,098.00

* Shipping/Handling is only charged once per order.

Contact Information
Please enter all the information below in BLOCK CAPITALS

      Title:                  Mr              Mrs           Dr           Miss                 Ms      Prof

      First Name:                                                  Last Name:

      Email Address: *

      Job Title:




      Postal / Zip Code:


      Phone Number:

      Fax Number:

     * Please refrain from using free email accounts when ordering (e.g. Yahoo, Hotmail, AOL)
Page 1 of 2
                                                              Page 2 of 2

Payment Information
Please indicate the payment method you would like to use by selecting the appropriate box.

          Pay by credit card:                     American Express

                                                  Diners Club

                                                  Master Card

                                           Cardholder's Name

                                           Cardholder's Signature

                                           Expiry Date

                                           Card Number

                                           CVV Number

                                           Issue Date
                                           (for Diners Club only)

          Pay by check:                    Please post the check, accompanied by this form, to:

                                           Research and Markets,
                                           Guinness Center,
                                           Taylors Lane,
                                           Dublin 8,

                                           Please transfer funds to:
          Pay by wire transfer:
                                           Account number                   833 130 83
                                           Sort code                        98-53-30
                                           Swift code                       ULSBIE2D
                                           IBAN number                      IE78ULSB98533083313083
                                           Bank Address                 Ulster Bank,
                                                                        27-35 Main Street,
                                                                        Co. Dublin,

     If you have a Marketing Code please enter it below:

           Marketing Code:

      Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at

                                              Please fax this form to:
                                  (646) 607-1907 or (646) 964-6609 - From USA
                          +353 1 481 1716 or +353 1 653 1571 - From Rest of World

To top